Delivery Order SPE2DB20D9127-SPE2DB22FPPH9

Award Date 8/25/22
Potential Completion Date 8/26/22
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $1,104.48, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that runs through December 31, 2025. The IDC allows DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including both common and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,778.48 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC covers a comprehensive range of...
This federal contract award, valued at $1,839.78, was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, under the SPE2DB program, allows the DLA to issue delivery orders...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $4,007.30 for the purchase of 4,565,213,035 units of Ondansetron HCL 4 mg tablets. The contract has a firm fixed-price pricing type and does not utilize any set-aside designations. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,021.90, is for the delivery of 4,565,078,614 Ondansetron HCL 4 MG tablets in packages of 500. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999,...
This federal contract award, valued at $21,409.49, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4565095622 - Ondansetron ODT 4 mg Tablet 30s. This award is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, which allows the DLA to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,968.95 contract is for the delivery of 4,564,878,259 tablets of 8 mg Ondansetron Orally Disintegrating Tablets. The order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group that allows the DLA to issue delivery orders for a wide range of pharmaceutical products...
This federal contract award, valued at $24,939.24, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, a $499,999,999 Indefinite Delivery Contract that enables the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health...
This federal contract award was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,399.77 firm fixed-price delivery order is for the supply of 4,564,618,079 units of Ondansetron HCL 4 MG Tablet 500S to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $2,003.65 firm fixed-price delivery order is for the supply of 500 units of the pharmaceutical drug Ondansetron HCL 4 mg tablet. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which enables the DLA to issue delivery...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB22FPPH9
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,021.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,558,233,358 units of Ondansetron HCL 4 mg tablets. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.

Generated 2/27/25, 10:09 AM